Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309383 · ClinicalTrials.gov registry record
ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 12
- Enrollment target
NCT04309383: Completed study, sponsored by University of South Florida.
NCT04309383 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04309383 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with pseudotumor cerebri.
Interventions
- DIAGNOSTIC_TEST ShuntCheck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2026-02-05 |
What the finished NCT04309383 record still lists
NCT04309383 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ShuntCheck is the first listed.
NCT04309383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04309383 about?
NCT04309383 is a clinical study titled "ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients". The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with pseudotumor cerebri.
What is the current status of trial NCT04309383?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-10-29. Estimated completion is 2026-02-05.
What interventions are being tested in trial NCT04309383?
The interventions under investigation include: ShuntCheck (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04309383?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI